NPCE
NeuroPace Inc
NASDAQ · Healthcare · Medical - Devices · US
$14.28
+0.92%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.11
- Revenue estimate
- $27.1M
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.18
- EPS estimate
- -$0.22
- Revenue actual
- $22.8M
- Revenue estimate
- $22.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +20.9%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Strong Buy
- Price target
- $20
- PT range
- $18 – $22
- Analysts
- 4
4 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.22 | -$0.18 | Beat 17.37% | $22.8M |
| May 12, 2026 | -$0.19 | -$0.13 | Beat 31.58% | $22.0M |
| Mar 3, 2026 | -$0.14 | -$0.08 | Beat 42.86% | $26.6M |
| Aug 12, 2025 | -$0.24 | -$0.26 | Miss -8.33% | $23.5M |
| Mar 4, 2025 | -$0.25 | -$0.18 | Beat 28.00% | $21.5M |
| Mar 5, 2024 | -$0.33 | -$0.23 | Beat 30.30% | $18.0M |
| May 4, 2023 | -$0.46 | -$0.41 | Beat 10.87% | $14.5M |
| Mar 2, 2023 | -$0.49 | -$0.45 | Beat 8.16% | $12.8M |
| Aug 11, 2022 | -$0.44 | -$0.52 | Miss -18.18% | $10.2M |
| May 12, 2022 | -$0.46 | -$0.47 | Miss -2.17% | $11.4M |
| Mar 10, 2022 | -$0.33 | -$0.44 | Miss -33.33% | $11.0M |
| Nov 10, 2021 | -$0.30 | -$0.34 | Miss -13.33% | $10.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026